Northside Hospital, Inc. clinical trial pipeline

5 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 3 with minor changes only.

1. Stopped

   Belumosudil and Rituximab for Primary Treatment of Chronic…Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

   Recruitment suspended

   Also in this update: Primary completion pushed from Dec 31, 2026 to Mar 31, 2027

   Northside Hospital, Inc.·Phase 2· NCT06046248· Registry history of NCT06046248 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical…Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

   Primary completion pushed from Jul 31, 2026 to Mar 31, 2027

   Also in this update: Study completion pushed from Dec 31, 2026 to Dec 31, 2027

   Northside Hospital, Inc.·Not specified· NCT05417971· Registry history of NCT05417971 on ClinicalTrials.gov (opens the registry)

   Oct 14, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.